Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

7,925 total articles

Nvidia Beat Fails to Spark Broader Chip Rally as Investors Question Capex and Cash Returns

Nvidia Beat Fails to Spark Broader Chip Rally as Investors Question Capex and Cash Returns

Nvidia reported fiscal fourth-quarter results that exceeded expectations, powered by record data-center revenue, but the company's beat did not lift the wider semiconductor sector. Shares of Nvidia and several peers fell as investors raised concerns about elevated capital spending, a reduced pace of shareholder returns and geopolitical uncertainty …

BIST 100 Edges Up as Leasing, Transport and Banking Stocks Lead Gains

BIST 100 Edges Up as Leasing, Transport and Banking Stocks Lead Gains

Turkey's BIST 100 closed higher, gaining 0.50% as advances in Leasing & Factoring, Transport and Banking stocks supported the market. Several individual names posted notable moves in both directions, while commodities and currency pairs showed moderate changes at the session's end in Istanbul. Overall breadth favoured decliners.

XSpray Resubmits Dasynoc to FDA, Eyes Two Oncology Launches in H2 2026

XSpray Resubmits Dasynoc to FDA, Eyes Two Oncology Launches in H2 2026

XSpray Pharma has re-filed its U.S. marketing application for Dasynoc with the Food and Drug Administration and expects a Prescription Drug User Fee Act (PDUFA) date to be assigned no later than August 2026. The company reaffirmed its timeline to introduce two oncology products in the second half of 2026 - Dasynoc and XS003 nilotinib - after addres…

Morgan Stanley Says Hyperscaler AI Capex to Surpass Dot-Com Peak

Morgan Stanley Says Hyperscaler AI Capex to Surpass Dot-Com Peak

Morgan Stanley warns that hyperscaler capital spending tied to AI will push cash capex-to-sales ratios above the dot-com era peak, driven by accelerated capex plans, rising lease use and concentrated investment inside major indexes, while revenue and free cash flow estimates lag behind spending revisions.

Lands’ End Shares Jump After WHP Global Files $45 Tender Offer

Lands’ End Shares Jump After WHP Global Files $45 Tender Offer

Lands’ End Inc. shares rose in premarket trading after WHP Global’s subsidiary LEWHP, LLC initiated a cash tender offer to buy up to 2,222,222 shares of the retailer at $45.00 per share. The offer, which is subject to proration if oversubscribed, will expire shortly after midnight New York time on March 26, 2026, and its completion is conditioned o…

Avalon GloboCare Rally After Entry to AMD AI Developer Program

Avalon GloboCare Rally After Entry to AMD AI Developer Program

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a steep premarket rise of 138.1% after announcing acceptance into the AMD AI Developer Program. The company says the program will give its AI subsidiary, Avalon Quantum AI LLC (AQAI), access to AMD Developer Cloud credits, hardware and software tools, training materials, and community resources intended to s…